[Special Stock] Alzheimer Early Diagnosis Related Stocks... PeopleBio Hits Upper Limit↑
PeopleBio, a company possessing technology related to the early diagnosis of Alzheimer's disease, has hit the upper price limit.
As of 2:05 PM on the 29th, PeopleBio is trading on the KOSDAQ market at 3,750 KRW, up 865 KRW (29.98%) from the previous day.
Founded in September 2002, PeopleBio is a company primarily engaged in pharmaceutical development using biotechnology, food ingredient development, chemical substance development and supply, and consulting.
The company's main product includes a blood test product that can be used for the early diagnosis of Alzheimer's disease, one of the representative degenerative brain diseases.
Hot Picks Today
"Not Even Daiso, but Prices from 1,000 to 7,000 Won" Crowds Flock... This Place Becomes Millennial & Gen Z Shopping Hotspot
- "Is It Really This Big?" World Number One in Sight... K-Beauty’s Surge Captivates Foreign Consumers with Trusted Korean Products
- "I'm Not Selling, I'm Still Waiting"... Why Jeon Wonju Holds Firm Despite a 9,000% Return on SK hynix
- "Surprised by How Handsome Lee Jae-yong Was in Middle School," Sami Ja Shares Unexpected Connection
- "Detecting Cancer Signals with a Single Mouth Rinse"...Remarkable Technology Developed by Korean Researchers [Reading Science]
Currently, the Alzheimer's blood test under the AlzOn brand is being conducted at 120 medical institutions nationwide, including advanced general hospitals, health screening centers, and clinics.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
